Advanced Medical Solutions Grp PLC Notice of Annual General Meeting and Annual Report (5459X)
30 April 2019 - 6:40PM
UK Regulatory
TIDMAMS
RNS Number : 5459X
Advanced Medical Solutions Grp PLC
30 April 2019
30 April 2019
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Annual Report and Accounts for the year ended
31 December 2018 and Notice of AGM
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, is pleased
to announce that in accordance with AIM Rules 20 and 26, the Annual
Report and Financial Statements for the year ended 31 December 2018
were posted to shareholders today and are available on the Investor
Relations section of the Company's website
http://www.admedsol.com/Investor-Relations.
The notice of meeting convening the Annual General Meeting of
the Company, which will be held on 5 June 2019 at 11 a.m. at the
Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, was also
posted to shareholders today and is available on the Company's
website.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Nicholas AMS@consilium-comms.com
Brown / Olivia Manser
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Patrick Robb / Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of products
that include tissue adhesives, sutures, biosurgical devices,
internal sealants, silver alginates, alginates and foams, which it
markets under its brands; LiquiBand(R), LiquiBand(R) Fix 8(TM),
RESORBA(R) and ActivHeal(R) as well as supplying under white
label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 630 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOAIMMPTMBJJMRL
(END) Dow Jones Newswires
April 30, 2019 04:40 ET (08:40 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024